Evidence map›Paper›PMID 38146786›Full record

ArticleYeast (Chichester, England)2024

Schizosaccharomyces versatilis represents a distinct evolutionary lineage of fission yeast.

Graham J Etherington, Elisa Gomez Gil, Wilfried Haerty, Snezhana Oliferenko, Conrad A Nieduszynski

Abstract read
In one paragraph

Article in Yeast (Chichester, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Molecular and cellular biology · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Graham J EtheringtonResearch Faculty, The Earlham Institute, Norwich Research Park, Norwich, UK.ORCID 0000-0002-5003-1425
Elisa Gomez GilOliferenko Lab, The Francis Crick Institute, London, UK.ORCID 0000-0001-9157-2028
Wilfried HaertyResearch Faculty, The Earlham Institute, Norwich Research Park, Norwich, UK.ORCID 0000-0003-0111-191X
Snezhana OliferenkoOliferenko Lab, The Francis Crick Institute, London, UK.ORCID 0000-0002-8138-6851
Conrad A NieduszynskiResearch Faculty, The Earlham Institute, Norwich Research Park, Norwich, UK.ORCID 0000-0003-2001-076X

Funding

BBSRC BB/T000481/1Biotechnology and Biological Sciences Research Council (BBSRC) BB/CCG1720/1EMBO postdoctoral fellowship ALTF 712-2022Wellcome TrustWellcome Trust Investigator Award in Science 220790/Z/20/Z
6 · The paper itself

Abstract

The fission yeast species Schizosaccharomyces japonicus is currently divided into two varieties-S. japonicus var. japonicus and S. japonicus var. versatilis. Here we examine the var. versatilis isolate CBS5679. The CBS5679 genome shows 88% identity to the reference genome of S. japonicus var. japonicus at the coding sequence level, with phylogenetic analyses suggesting that it has split from the S. japonicus lineage 25 million years ago. The CBS5679 genome contains a reciprocal translocation between chromosomes 1 and 2, together with several large inversions. The products of genes linked to the major translocation are associated with 'metabolism' and 'cellular assembly' ontology terms. We further show that CBS5679 does not generate viable progeny with the reference strain of S. japonicus. Although CBS5679 shares closer similarity to the 'type' strain of var. versatilis as compared to S. japonicus, it is not identical to the type strain, suggesting population structure within var. versatilis. We recommend that the taxonomic status of S. japonicus var. versatilis is raised, with it being treated as a separate species, Schizosaccharomyces versatilis.

Indexed as

SchizosaccharomycesBiological EvolutionPhylogenyadaptationevolutionfission yeastSchizosaccharomyces versatilistaxonomy

Identifiers

PMID38146786
PMCPMC7619371

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.